|
Category: natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Flash Point: | 32.00 °F. TCC ( 0.00 °C. ) (est)
|
| Soluble in: |
| | water, 6.67E+05mg/L @ 15 °C (exp) | | | water, 3.801e+005 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
parenteral-frog LDLo 375 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 27, Pg. 431, 1926.
intraperitoneal-guinea pig LDLo 42 mg/kg Journal of Agricultural Research Vol. 32, Pg. 51, 1926.
intraperitoneal-mouse LD50 43 mg/kg Journal of Medicinal Chemistry. Vol. 20, Pg. 1668, 1977.
intravenous-mouse LD50 15 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
BEHAVIORAL: STIFFNESS Japanese Journal of Pharmacology. Vol. 16, Pg. 353, 1966.
oral-mouse LD50 350 mg/kg BEHAVIORAL: EXCITEMENT Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1497, 1980.
intravenous-rat LD50 30400 ug/kg BEHAVIORAL: STIFFNESS
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) Japanese Journal of Pharmacology. Vol. 16, Pg. 353, 1966.
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 117 mg/kg BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: STIFFNESS Japanese Journal of Pharmacology. Vol. 16, Pg. 353, 1966.
subcutaneous-rabbit LDLo 80 mg/kg VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION Journal of Pharmacology and Experimental Therapeutics. Vol. 27, Pg. 431, 1926.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | natural substances and extractives |
| Recommendation for sparteine sulfate anhydrous usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for sparteine sulfate anhydrous flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
| EPI System: | View |
| AIDS Citations: | Search |
| Cancer Citations: | Search |
| Toxicology Citations: | Search |
| EPA ACToR: | Toxicology Data |
| EPA Substance Registry Services (SRS): | Registry |
| Laboratory Chemical Safety Summary : | 9293 |
| National Institute of Allergy and Infectious Diseases: | Data |
| | (1R,2S,9R,10R)-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane;sulfuric acid |
| Chemidplus: | 0000299398 |
References:
| | (1R,2S,9R,10R)-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane;sulfuric acid |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 9293 |
| Pubchem (sid): | 134975117 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | actospar | | | depasan | | (1R,2S,9R,10R)-7,15- | diazatetracyclo[7.7.1.02,7.010,15]heptadecane;sulfuric acid | | 7,14- | methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))-, sulfate (1:1) (9CI) | | | siarczan sparteiny | | | spareng | | | sparteine sulfate | | | sparteine sulphate anhydrous | | | sparteine, sulfate (1:1) (8CI) | | | spartepur | | | spartin | | | spartocin | | | spatym | | | tocosamine sulfate | | | tocosimplex |
Articles:
|